Novaquest Capital Management

What they do

NovaQuest Capital Management, LLC (NovaQuest) manages product and company investments in the global healthcare industry. Its primary focus is structured finance investments in late-stage clinical and commercialized biopharmaceutical products. NovaQuest invests side-by-side with global companies in their most strategic product programs, ensuring alignment with the biopharmaceutical companies. These customized, product transactions are an alternative to standard biopharmaceutical industry deal-making and help companies maximize the value of their product portfolios. In addition, NovaQuest invests in select private equity and other company securities, with a consistent focus on late-stage clinical and commercialized products. The NovaQuest team has worked together for over 12 years, investing over $1 billion into the global healthcare industry. The team began pursuing its strategy in 2000 as an investment group within Quintiles Transnational Holdings Inc. (Quintiles). Today, NovaQuest Capital Management is an independent firm managing global investment capital. It is backed by investors whose relationships with NovaQuest date back to the group’s inception. NovaQuest is meeting the evolving needs of global healthcare companies and its investors with a consistent strategy, developed over multiple years and transactions, that draws on a customized mix of investment and return elements and securities.

What they look for

PRODUCT FINANCE™ investing was developed by NovaQuest's founders over 20 years ago as a tailored capital solution to support pivotal clinical trials and product launches, typically deployed through a nondilutive and noncontrolling investment structure. We are passionate about funding innovation in biopharmaceutical development.

Stage

Series B+

Sectors

Healthcare

Based

Raleigh, US